Mallory Kerner

1.2k citations

24 papers · 628 indexed · h-index 16

Cellular and Molecular Neuroscience top 10%
Psychiatry and Mental health top 5%
Pharmacology top 10%
Cognitive Neuroscience top 10%
Physiology

Co-authors: Kenneth Blum Eric R. Braverman Thomas J.H. Chen Roger L. Waite Bernard W. Downs Seth H. Blum Amanda LC Chen Marlene Oscar‐Berman
Topics: Neurotransmitter Receptor Influence on Behavior (7 papers)Attention Deficit Hyperactivity Disorder (6 papers)Stress Responses and Cortisol (2 papers)
Cited by: Psychiatry and Mental health Cellular and Molecular Neuroscience Behavioral Neuroscience
Journals: PLoS ONE Molecular Neurobiology BMC Musculoskeletal Disorders
Partner nations: United States Taiwan Israel

In The Last Decade

Mallory Kerner

24 papers receiving 576 citations

Peers

Countries citing papers authored by Mallory Kerner

Since Specialization

Citations

This map shows the geographic impact of Mallory Kerner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mallory Kerner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mallory Kerner more than expected).

Fields of papers citing papers by Mallory Kerner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mallory Kerner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mallory Kerner. The network helps show where Mallory Kerner may publish in the future.

Co-authorship network of co-authors of Mallory Kerner

This figure shows the co-authorship network connecting the top 25 collaborators of Mallory Kerner. A scholar is included among the top collaborators of Mallory Kerner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mallory Kerner. Mallory Kerner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Evoked Potentials and Neuropsychological Tests Validate Positron Emission Topography (PET) Brain Metabolism in Cognitively Impaired Patients 2013 ·PLoS ONE ·Eric R. Braverman,Kenneth Blum,(unknown),Mallory Kerner,Kristina Dushaj,Marlene Oscar‐Berman	11
2	Neuropsychopharmacology and Neurogenetic Aspects of Executive Functioning: Should Reward Gene Polymorphisms Constitute a Diagnostic Tool to Identify Individuals at Risk for Impaired Judgment? 2012 ·Molecular Neurobiology ·Abdalla Bowirrat,Thomas J.H. Chen,Marlene Oscar‐Berman,Margaret Madigan,(unknown),John Bailey,Eric R. Braverman,Mallory Kerner,John Giordano,Siobhan Morse,Bernard W. Downs,Roger L. Waite,(unknown),Zaher Armaly,Kenneth Blum	22
3	Neurogenetics and Clinical Evidence for the Putative Activation of the Brain Reward Circuitry by a Neuroadaptagen: Proposing an Addiction Candidate Gene Panel Map 2011 ·Journal of Psychoactive Drugs ·Thomas J.H. Chen,Kenneth Blum,Amanda LC Chen,Abdalla Bowirrat,William B. Downs,(unknown),Roger L. Waite,John Bailey,Mallory Kerner,(unknown),Neil Majmundar,John Giordano,(unknown),David Miller,(unknown),Eric R. Braverman	35
4	Can the Chronic Administration of the Combination of Buprenorphine and Naloxone Block Dopaminergic Activity Causing Anti-reward and Relapse Potential? 2011 ·Molecular Neurobiology ·Kenneth Blum,Thomas J.H. Chen,John Bailey,Abdalla Bowirrat,John Femino,Amanda LC Chen,Thomas Simpatico,Siobhan Morse,John Giordano,(unknown),Mallory Kerner,Eric R. Braverman,(unknown),Bernard W. Downs,(unknown),Debmalya Barh,Marlene Oscar‐Berman	26
5	Neuro-psychopharmacogenetics and Neurological Antecedents of Posttraumatic Stress Disorder: Unlocking the Mysteries of Resilience and Vulnerability 2010 ·Current Neuropharmacology ·Abdalla Bowirrat,Thomas J.H. Chen,Kenneth Blum,Margaret Madigan,John Bailey,(unknown),Bernard W. Downs,Eric R. Braverman,Radi Shahien,Roger L. Waite,Mallory Kerner,John Giordano,(unknown),Marlene Oscar‐Berman,Mark S. Gold	45
6	Healing enhancement of chronic venous stasis ulcers utilizing H-WAVE®device therapy: a case series 2010 ·Cases Journal ·Kenneth Blum,(unknown),(unknown),Bernard W. Downs,Eric R. Braverman,Mallory Kerner,(unknown),(unknown),Margaret Madigan,Seth H. Blum,(unknown),John Giordano,Nicholas A. DiNubile	5
7	Overcoming qEEG Abnormalities and Reward Gene Deficits during Protracted Abstinence in Male Psychostimulant and Polydrug Abusers Utilizing Putative Dopamine D₂Agonist Therapy: Part 2 2010 ·Postgraduate Medicine ·Kenneth Blum,Thomas J.H. Chen,Siobhan Morse,John Giordano,(unknown),James T. Thompson,(unknown),Andrew Smolen,Joel F. Lubar,Eric Stice,Bernard W. Downs,Roger L. Waite,Margaret Madigan,Mallory Kerner,(unknown),Eric R. Braverman	71
8	Adult growth hormone deficiency treatment with a combination of growth hormone and insulin-like growth factor-1 resulting in elevated sustainable insulin-like growth factor-1 and insulin-like growth factor binding protein 3 plasma levels: a case report 2010 ·Journal of Medical Case Reports ·Eric R. Braverman,Abdalla Bowirrat,(unknown),(unknown),(unknown),Margaret Madigan,Mallory Kerner,(unknown),(unknown),Kenneth Blum	3
9	Repetitive H-Wave® device stimulation and program induces significant increases in the range of motion of post operative rotator cuff reconstruction in a double-blinded randomized placebo controlled human study 2009 ·BMC Musculoskeletal Disorders ·Kenneth Blum,Amanda LC Chen,Thomas J.H. Chen,Roger L. Waite,Bernard W. Downs,Eric R. Braverman,Mallory Kerner,(unknown),Nicholas A. DiNubile	17
10	Do dopaminergic gene polymorphisms affect mesolimbic reward activation of music listening response? Therapeutic impact on Reward Deficiency Syndrome (RDS) 2009 ·Medical Hypotheses ·Kenneth Blum,Thomas J.H. Chen,(unknown),Margaret Madigan,Bernard W. Downs,Roger L. Waite,Eric R. Braverman,Mallory Kerner,Abdalla Bowirrat,John Giordano,(unknown),Mark S. Gold	40
11	Age-related increases in parathyroid hormone may be antecedent to both osteoporosis and dementia 2009 ·BMC Endocrine Disorders ·Eric R. Braverman,Thomas J.H. Chen,Amanda LC Chen,Vanessa Arcuri,Mallory Kerner,(unknown),(unknown),(unknown),Bernard W. Downs,Kenneth Blum	13
12	Preliminary investigation of plasma levels of sex hormones and human growth factor(s), and P300 latency as correlates to cognitive decline as a function of gender 2009 ·BMC Research Notes ·Eric R. Braverman,Thomas J.H. Chen,Amanda LC Chen,Mallory Kerner,Howard Tung,Roger L. Waite,John Schoolfield,Kenneth Blum	10
13	Nutrigenomic targeting of carbohydrate craving behavior: Can we manage obesity and aberrant craving behaviors with neurochemical pathway manipulation by Immunological Compatible Substances (nutrients) using a Genetic Positioning System (GPS) Map? 2009 ·Medical Hypotheses ·Bernard W. Downs,Amanda LC Chen,Thomas J.H. Chen,Roger L. Waite,Eric R. Braverman,Mallory Kerner,(unknown),Patrick Rhoades,Thomas J. Prihoda,Tomás Palomo,Marlene Oscar‐Berman,Jeffrey Reinking,Seth H. Blum,Nicholas A. DiNubile,(unknown),Kenneth Blum	21
14	Putative targeting of Dopamine D2 receptor function in Reward Deficiency Syndrome (RDS) by Synaptamine Complex™ Variant (KB220): Clinical trial showing anti-anxiety effects 2009 ·Kenneth Blum,(unknown),(unknown),Abdalla Bowirrat,Roger L. Waite,Mallory Kerner,Seth H. Blum,Bernard W. Downs,Patrick Rhoades,Jeffrey Reinking,Eric R. Braverman,Nicholas A. DiNubile	15
15	LG839: Anti-obesity effects and polymorphic gene correlates of reward deficiency syndrome 2008 ·Advances in Therapy ·Kenneth Blum,Amanda LC Chen,Thomas J.H. Chen,Patrick Rhoades,Thomas J. Prihoda,Bernard W. Downs,Roger L. Waite,(unknown),Eric R. Braverman,(unknown),Vanessa Arcuri,Mallory Kerner,Seth H. Blum,Tomás Palomo	41
16	The H-Wave® device is an effective and safe non-pharmacological analgesic for chronic pain: a meta-analysis 2008 ·Advances in Therapy ·Kenneth Blum,Amanda LC Chen,Thomas J.H. Chen,Thomas J. Prihoda,John Schoolfield,Nicholas A. DiNubile,Roger L. Waite,Vanessa Arcuri,Mallory Kerner,Eric R. Braverman,Patrick Rhoades,Howard Tung	17
17	Activation instead of blocking mesolimbic dopaminergic reward circuitry is a preferred modality in the long term treatment of reward deficiency syndrome (RDS): a commentary 2008 ·Theoretical Biology and Medical Modelling ·Kenneth Blum,(unknown),Thomas J.H. Chen,Eric R. Braverman,Jeffrey Reinking,Seth H. Blum,(unknown),Bernard W. Downs,Roger L. Waite,(unknown),Thomas J. Prihoda,Mallory Kerner,Tomás Palomo,David E. Comings,Howard Tung,Patrick Rhoades,Marlene Oscar‐Berman	112
18	Hypothesizing that brain reward circuitry genes are genetic antecedents of pain sensitivity and critical diagnostic and pharmacogenomic treatment targets for chronic pain conditions 2008 ·Medical Hypotheses ·Amanda LC Chen,Thomas J.H. Chen,Roger L. Waite,Jeffrey Reinking,Howard Tung,Patrick Rhoades,Bernard W. Downs,Eric R. Braverman,(unknown),Mallory Kerner,Seth H. Blum,Nicholas A. DiNubile,David E. Smith,Marlene Oscar‐Berman,Thomas J. Prihoda,(unknown),David O’Brien,(unknown),Kenneth Blum	36
19	Hypothesizing that Marijuana Smokers are at a Significantly Lower Risk of Carcinogenicity Relative to Tobacco-Non-Marijuana Smokers: Evidenced Based on Statistical Reevaluation of Current Literature 2008 ·Journal of Psychoactive Drugs ·Amanda LC Chen,Thomas J.H. Chen,Eric R. Braverman,(unknown),Mallory Kerner,(unknown),(unknown),William B. Downs,Seth H. Blum,(unknown),Kenneth Blum	9
20	A short term pilot open label study to evaluate efficacy and safety of LG839, a customized DNA directed nutraceutical in obesity: Exploring Nutrigenomics 2008 ·Kenneth Blum,Thomas J.H. Chen,(unknown),(unknown),William B. Downs,Roger L. Waite,(unknown),Simon H. Sims,Thomas J. Prihoda,(unknown),Jeffrey Reinking,(unknown),Mallory Kerner,Seth H. Blum,(unknown),Eric R. Braverman	23

About Mallory Kerner

Mallory Kerner is a scholar working on Behavioral Neuroscience, Psychiatry and Mental health and Cellular and Molecular Neuroscience, having authored 24 papers that have together received 628 indexed citations. Recurring topics across this work include Neurotransmitter Receptor Influence on Behavior (7 papers), Attention Deficit Hyperactivity Disorder (6 papers) and Stress Responses and Cortisol (2 papers). The work is most often cited by research in Psychiatry and Mental health (221 citations), Cellular and Molecular Neuroscience (252 citations) and Behavioral Neuroscience (41 citations). Mallory Kerner has collaborated with scholars based in United States, Taiwan and Israel. Frequent co-authors include Kenneth Blum, Eric R. Braverman, Thomas J.H. Chen, Roger L. Waite, Bernard W. Downs, Seth H. Blum, Amanda LC Chen, Marlene Oscar‐Berman, John Giordano and Thomas J. Prihoda. Their work appears in journals such as PLoS ONE, Molecular Neurobiology and BMC Musculoskeletal Disorders.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact